» Articles » PMID: 37957625

Comparative Immunological Landscape Between Pre- and Early-stage LUAD Manifested As Ground-glass Nodules Revealed by ScRNA and ScTCR Integrated Analysis

Overview
Publisher Biomed Central
Date 2023 Nov 14
PMID 37957625
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mechanism underlying the malignant progression of precancer to early-stage lung adenocarcinoma (LUAD) as well as their indolence nature remains elusive.

Methods: Single-cell RNA sequencing (scRNA) with simultaneous T cell receptor (TCR) sequencing on 5 normal lung tissues, 3 precancerous and 4 early-stage LUAD manifested as pulmonary ground-glass nodules (GGNs) were performed.

Results: Through this integrated analysis, we have delineated five key modules that drive the malignant progression of early-stage LUAD in a disease stage-dependent manner. These modules are related to cell proliferation and metabolism, immune response, mitochondria, cilia, and cell adhesion. We also find that the tumor micro-environment (TME) of early-stage LUAD manifested as GGN are featured with regulatory T (Tregs) cells accumulation with three possible origins, and loss-functional state (decreased clonal expansion and cytotoxicity) of CD8 + T cells. Instead of exhaustion, the CD8 + T cells are featured with a shift to memory phenotype, which is significantly different from the late stage LUAD. Furthermore, we have identified monocyte-derived macrophages that undergo a lipid-phenotype transition and may contribute to the suppressive TME. Intense interaction between stromal cells, myeloid cells including lipid associated macrophages and LAMP3 + DCs, and lymphocytes were also characterized.

Conclusions: Our work provides new insight into the molecular and cellular mechanism underlying malignant progression of LUAD manifested as GGN, and pave way for novel immunotherapies for GGN. Video Abstract.

Citing Articles

Early precise screening of pulmonary nodules: risk factor analysis for malignant nodules.

Zhao Q, Wang T Am J Transl Res. 2024; 16(11):6615-6625.

PMID: 39678584 PMC: 11645618. DOI: 10.62347/DTPQ4790.


The immune microenvironment of lung adenocarcinoma featured with ground-glass nodules.

Zhao C, Xiao R, Jin H, Li X Thorac Cancer. 2024; 15(19):1459-1470.

PMID: 38923346 PMC: 11219292. DOI: 10.1111/1759-7714.15380.


Signaling, cancer cell plasticity, and intratumor heterogeneity.

Cordani M, Dando I, Ambrosini G, Gonzalez-Menendez P Cell Commun Signal. 2024; 22(1):255.

PMID: 38702718 PMC: 11067149. DOI: 10.1186/s12964-024-01643-5.

References
1.
Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

2.
Liu B, Hu X, Feng K, Gao R, Xue Z, Zhang S . Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat Cancer. 2022; 3(1):108-121. DOI: 10.1038/s43018-021-00292-8. View

3.
Batista-Gonzalez A, Vidal R, Criollo A, Carreno L . New Insights on the Role of Lipid Metabolism in the Metabolic Reprogramming of Macrophages. Front Immunol. 2020; 10:2993. PMC: 6966486. DOI: 10.3389/fimmu.2019.02993. View

4.
Skon C, Lee J, Anderson K, Masopust D, Hogquist K, Jameson S . Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat Immunol. 2013; 14(12):1285-93. PMC: 3844557. DOI: 10.1038/ni.2745. View

5.
Pennycuick A, Teixeira V, AbdulJabbar K, Raza S, Lund T, Akarca A . Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer. Cancer Discov. 2020; 10(10):1489-1499. PMC: 7611527. DOI: 10.1158/2159-8290.CD-19-1366. View